Merck KGaA (OTCMKTS:MKGAF) Stock Price Passes Above 50-Day Moving Average of $168.97

Merck KGaA (OTCMKTS:MKGAFGet Free Report)’s stock price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $168.97 and traded as high as $183.42. Merck KGaA shares last traded at $183.42, with a volume of 4 shares.

Merck KGaA Trading Up 2.7 %

The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.89 and a current ratio of 1.42. The firm has a fifty day moving average price of $168.97 and a 200 day moving average price of $166.12. The company has a market cap of $23.70 billion, a price-to-earnings ratio of 26.93 and a beta of 0.97.

Merck KGaA (OTCMKTS:MKGAFGet Free Report) last announced its quarterly earnings results on Wednesday, May 15th. The company reported $1.74 EPS for the quarter, missing analysts’ consensus estimates of $1.92 by ($0.18). Merck KGaA had a net margin of 13.09% and a return on equity of 11.69%. The firm had revenue of $5.56 billion during the quarter. As a group, equities analysts predict that Merck KGaA will post 9.73 EPS for the current fiscal year.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Further Reading

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.